Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • DOJ Notified News Corp. About Phone-Record Seizure
  • French Soldier Injured in Attack Outside Paris
  • Three More Detained in Soldier's Killing
  • Victory At Last for Big, Bad, Bayern
  • Interpol Rejects Russia Bid to Locate U.K. Investor
  • DOJ Notified News Corp. About Phone-Record Seizure
  • Guest Post: Our American Pravda
  • The new farm bill is an economic disaster | Heidi Moore
  • Is Ryanair really Europe's most punctual airline?
  • Sunday ET | Meet the grand old men of hotel industry

    Preoccupations: An Actuary Proves Patents Aren’t Only for Engineers

    Sat, 05/12/2012 - 18:01 EDT - NY Times
    • Insurance
    • Inventions and Patents
    • Mathematics
    • Patent and Trademark Office
    • Towers Watson

    An actuary describes the long and winding road to obtaining a patent — in his case, for a statistical sampling method that can be used by insurance companies.

    • Original article
    • Login or register to post comments
     

    Related

    • The Supreme Court Will Decide Whether Biotech Companies Can Own Your Genes

      The US Supreme Court heard the most high-profile genetics case in history on Monday, as justices considered whether private firms should be allowed to patent human genes linked to breast cancer.

    • A Farmer's Crusade Against Monsanto Could Determine The Future Of Patents

      The U.S. Supreme Court heard a huge fight over seed patents Tuesday that pits an Indiana farmer against agribusiness giant Monsanto.

    • A Court Is About To Determine The Fate Of Software Patents And The Implications Are Massive

      A federal appeals court is set to consider a case closely watched by Google Inc, Facebook Inc and other technology companies that could determine how far the patent system should go in protecting software inventions.

    • Judge Robart’s patent medicine

      WITHOUT technical standards, life would be a lot more complicated. They make it possible, for example, for computers of all sorts to connect to the internet via Wi-Fi in homes, offices and coffee shops, and for mobile phones of different makes on different networks to communicate with one another.

    • Google countersues BT over patents

    • Is The Obama Administration Really This Clueless About US Companies' Global Competitiveness?

      In Sunday's Chicago Tribune, Caterpillar CEO Doug Oberhelman explained why his manufacturing powerhouse has no plans to expand business operations in its home state of Illinois.  The whole op-ed is worth reading, but here are the money grafs:

    • Business Secretary seals agreement to bring patent court to London

      The new court and patent system creates a one-stop shop for companies wanting to protect their business ideas in Europe and will bring at least £200 million to the economy each year.

    • Monsanto Has Been Suing Small Famers To Protect Its Seed Patents

      The agricultural giant Monsanto has sued hundreds of small farmers in the United States in recent years in attempts to protect its patent rights on genetically engineered seeds that it produces and sells, a new report said on Tuesday.

    • Does Innovation Require the Patent Office?

      Two years ago, I spoke to a gentlemen who had started and sold four companies. He was currently working on a new project that sounded very promising (for all I know, he has already sold that one too). We had just heard a talk in which the speaker told people that the whole key to business success in our time is patent ownership. Without it, no business can really succeed. So I asked this gentleman what he thought of the talk. His response was quick (I paraphrase here):

    • Can You Really Patent A Gene?

      The question of whether genetic material can or should be patented by pharmaceutical companies is being tested in courts both in the U.S. and overseas.   On Monday, the U.S. Supreme Court heard an appeal by the American Civil Liberties Union and the Public Patent Foundation against Myriad Genetics Inc., a Utah-based private biotechnology company that holds patents on the BRCA1 and BRCA2 genes, two genetic mutations associated with breast and ovarian cancer.  

    Latest

    REPORT: SAC Capital's Biggest Outside Investor Wants To Pull Money Out
    REPORT: SAC Capital's Biggest Outside...
    3 Teeth-Whitening Products That Actually Work
    3 Teeth-Whitening Products That Actually Work

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Tata Steel, ECB, China’s car market and European Corporate Tax in Our News for Today 05/24/2013
    • Pandora: the charm might fade away
    • Japanese Market, Indian Rupee, China’s Stocks and Oil Prices in Our Daily Round-Up for 05/23/2013

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1649.60 -0.06% FTSE: 6654.34 -0.64% Nikk.: 14612.45 0.88% DAX: 8305.32 -0.56% HSI: 22618.67 -0.23% FX: EUR/GBP: 1.1694 USD/EUR: 1.2935 JPY/USD: 101.175 Commodities: Gold: 1386.60

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions